Photodynamic therapy may worsen the prognosis of highly myopic choroidal neovascularisation treated by intravitreal bevacizumab

British Journal of Ophthalmology

Volumn 93, Issue 12, 2009, Pages 1693-1694

  Ruiz Moreno, J M ^a,b   Montero, J A ^b,c   Gomez Ulla, F ^d,e  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b Alicante   (Spain)

^c HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^d Technological Institute of Ophthalmology   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; VERTEPORFIN;

ADULT; AGED; CHORIORETINOPATHY; CHOROID CAPILLARY LAYER; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; EYE EXAMINATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HIGH MYOPIA; HUMAN; LETTER; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROGNOSIS; RETINA DISEASE; SUBRETINAL NEOVASCULARIZATION; TREATMENT FAILURE; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOPIA; PHOTOCHEMOTHERAPY; PROGNOSIS;

EID: 72449163618     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.147611     Document Type: Letter

References (6)

1. Ruiz-Moreno JM, Montero JA, Gomez-Ulla F, et al. Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome. Br J Ophthalmol 2009;93:448-451
2. Sakaguchi H, Ikuno Y, Gomi F, et al. Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Br J Ophthalmol 2007;91:161-165 (Pubitemid 46202863)
3. Verteporfin in photodynamic therapy (VIP) study group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial - VIP report no. 1. Ophthalmology 2001;108:841-852
4. Postelmans L, Pasteels B, Coquelet P, et al. Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females. Am J Ophthalmol 2004;138:803-808 (Pubitemid 39452928)
5. Montero JA, Ruiz-Moreno JM. Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation. Br J Ophthalmol 2003;87:173-176 (Pubitemid 36152743)
6. Ruiz-Moreno JM, Amat P, Montero J, et al. Photodynamic therapy to treat choroidal neovascularisation in highly myopic patients: 4 years' outcome. Br J Ophthalmol 2008;92:792-794 (Pubitemid 351839570)